Amgen Probe Widens As Former Reps Take Action

Law360, New York (February 12, 2008, 12:00 AM EST) -- An investigation into Amgen Inc.'s alleged privacy violations has widened as two former sales representatives take legal action against the company, seeking to recover compensation they say they lost after objecting to the way psoriasis drug Enbrel was marketed.

Elena Ferrante and Marc Engelman “were being directed to aggressively and unethically sell the drug,” said Lydia Cotz, attorney with Cotz & Cotz in Mahwah, N.J., who represents the former salespeople.

Cotz said she has received requests for documents or interviews from the U.S. Securities and Exchange...
To view the full article, register now.